Side effects of drugs annual. a worldwide yearly survey of new data in adverse drug reactions / Volume 37 :

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a rel...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ray, Sidhartha D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam, Netherlands : Elsevier, 2015.
Temas:
Drugs > Side effects.
Drug-Related Side Effects and Adverse Reactions
M�edicaments > Effets secondaires.
MEDICAL > Pharmacology.
Drugs > Side effects
Acceso en línea:Texto completo
Texto completo
Tabla de Contenidos:
  • Title page; Table of Contents; Copyright; Contributors; Preface; Special Reviews in SEDA 37; Table of Essays, Annuals 1-36; Abbreviations; ADRs, ADEs and SEDs: A Bird's Eye View; I Introduction; References on Adverse Drug Reactions; II Pharmacogenomics Considerations; References Pharmacogenomics Considerations; III Immunological Reactions; References; IV Analysis of Toxicological Reactions; References; V Grades of Adverse Drug Reactions; References; VI FDA Pregnancy Categories/Classification of teratogenicity; References; Conclusion.
  • Chapter 1: Central Nervous System Stimulants and Drugs That Suppress AppetiteAbstract; Methylxanthines; Vigilance Promoting Drugs; Parasympathomimetics [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; Chapter 2: Antidepressants; Abstract; General; Selective Serotonin Re-Uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30; SEDA-36, 14]; Serotonin and Noradrenaline Re-Uptake Inhibitors (SNRIs); Other Antidepressants; Chapter 3: Lithium; Abstract; Introduction; Organs and Systems; Second-Generation Effects; Susceptibility Factors; Interactions.
  • Diagnosis of Adverse Drug ReactionsManagement of Adverse Drug Reactions; Pharmacogenomics; Chapter 4: Drugs of Abuse; Abstract; Introduction; Cannabinoid; Alcohol; Benzodiazepines; Sympathomimetics-Cocaine; Opioids-Heroin; Electronic Cigarettes (E-Cigarettes); Conclusion; Chapter 5: Hypnosedatives and Anxiolytics; Abstract; Benzodiazepines; Hypnosedatives and Benzodiazepine-Like Drugs; Chapter 6: Antipsychotic Drugs; Abstract; General [SEDA-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85; SEDA-36, 59]; Individual Drugs; Acknowledgements; Chapter 7: Antiepileptics; Abstract.
  • Chapter 8: Opioid Analgesics and Narcotic AntagonistsAbstract; Opioid Receptor Agonists; Alfentanil [SED-15, 72; SEDA-34, 152; SEDA-35, 173; SEDA-36, 108]; Codeine [SED-15, 880; SEDA -34, 152; SEDA-35, 174; SEDA-36, 108]; Dextrometrophan [SED-15, 1088; SEDA-34, 153; SEDA-35, 174; SEDA-36, 108]; Diamorphine [SED-15, 1096; SEDA-34, 153; SEDA-35, 175; SEDA-36, 108]; Dihydrocodeine [SED-15, 1125; SEDA-34, 154; SEDA-35, 175; SEDA-36, 108]; Fentanyl [SED-15, 1346; SEDA-34, 154; SEDA-35, 176; SEDA-36, 109]; Hydrocodone [SED-15, 1702; SEDA-34, 156; SEDA-35, 177; SEDA-36, 109]
  • Methadone [SED-15, 2270 SEDA-34, 157; SEDA-35, 177; SEDA-36, 110]; Morphine [SED-15, 2386; SEDA-34, 159; SEDA-35, 181; SEDA-36, 111]; Oxycodone [SED-15, 2651; SEDA-34, 161; SEDA-35, 182; SEDA-36, 111]; Papaverine [SED-15, 2678; SEDA-34, 162; SEDA-35, 183; SEDA-36, 112]; Pethidine (Meperidine) [SED-15, 2791; SEDA-34, 163; SEDA-35, 183; SEDA-36, 112]; Remifentanyl [SED-15, 3030; SEDA-34, 163; SEDA-35, 184; SEDA-36, 112]; Tramadol [SED-15, 3469; SEDA-34, 165; SEDA-35, 184; SEDA-36, 112]; Partial Opioid Receptor Agonists; Opioid Receptor Antagonists; Naloxone [SED-15, 2421.

Ejemplares similares